Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICM Biotech Australia
Melbourne, Victoria, Australia
- Ownership
- Private
- Development stage
- Other
01
Overview
ICM Biotech is an Australian biotechnology company focused on developing first-in-class small molecule inhibitors targeting Macrophage Migration Inhibitory Factor (MIF). The company's lead programs aim to address significant unmet needs in oncology and inflammatory diseases by modulating the pro-inflammatory and pro-tumorigenic effects of MIF. Their research is based on intellectual property licensed from Monash University and the Hudson Institute of Medical Research. ICM Biotech is currently advancing its lead candidates through pre-clinical development with the goal of entering clinical trials for solid tumors and chronic inflammatory conditions.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Monash UniversityHudson Institute of Medical Research
Beyond the preview
Go deeper on ICM Biotech Australia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ICM Biotech Australia.